Search

A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.

… Monday, June 22, 2020 A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD , medical oncologist at MSK

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone marrow transplants for blood cancer.

… Friday, September 28, 2018 Bottom Line: A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone

Take a short quiz to test your knowledge of breast cancer screening.

… Tuesday, October 3, 2017 Summary Does breast cancer screening hurt? How often should you get a mammogram? Get the answers to these questions and more by taking this quiz. It can be hard to stay on top of current breast cancer screening guidelines because the advice is sometimes confusing or conflicting

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Thursday, November 18, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

… Friday, January 13, 2012 Summary Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy. Researchers at Memorial Sloan Kettering have shown the usefulness of a scale

An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.

… Monday, April 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that  Jeffrey A. Drebin, MD, PhD , has been named President-Elect of the  American Surgical Association (ASA) for 2024. An internationally recognized surgeon-scientist and the Chair of MSK’s Department of Surgery,

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.

… Monday, October 28, 2024 Obesity or being overweight can  increase your risk of developing cancer . It can lead to chronic inflammation and hormonal changes, which can damage DNA and cause uncontrolled cell growth.  Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.

… Friday, April 19, 2019 In a first-of-its-kind collaboration, Memorial Sloan Kettering has joined forces with the Chinese Thoracic Oncology Group (CTONG) — an alliance of more than 20 premier academic cancer centers in China — in an effort to establish a program of clinical trials that are open to patients

在史上首次该类型合作中，MSK 与中国胸部肿瘤研究协作组将携手共进，共同打造一个对来自美国和中国的患者都开放的临床试验项目。

… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作，努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国，肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动，旨在为中美两国的多中心 临床试验 奠定学术基础，最终目标是提高临床试验参与率，推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施，包括远程医疗和教育举措，旨在改善两国患者的护理状况，并努力推动行业参与。 为获得该领域的指导

While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.

… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.